# FDA recall D-1048-2017

> **Hospira a Pfizer Company** · Class II · drug recall initiated 2017-06-15.

## Product

Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL,  For I.V. or I.M. use.  a.) one vial (NDC: 0409-6629-02), b.) 25 vial carton (NDC: 0409-6629-25).

## Reason for recall

Lack of Sterility Assurance

## Distribution

U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore

## Key facts

- **Recall number:** D-1048-2017
- **Recalling firm:** Hospira a Pfizer Company
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-06-15
- **Report date:** 2017-08-09
- **Termination date:** 2020-07-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Rocky Mount, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1048-2017

## Citation

> AI Analytics. FDA recall D-1048-2017. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-1048-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*